Fig 4.

Quality-of-life questionnaire. The bar graphs indicate the patients' replies to a questionnaire that assessed satisfaction with and preferences for the histrelin implant compared with IM depot GnRHa treatment for CPP. Patients reported less pain and/or discomfort associated with the implant compared with depot GnRHa treatment (P < .005). Patients reported less disruption of school, work, and other activities during implant treatment as compared with standard therapy (P < .05).